Developer of advanced transdermal drug delivery technologies and prescription transdermal products. Products are sold to the pharmaceutical industry. The bulk of revenue is derived from activity in the medical industry. This company was capitalized by private investment and venture capital. Stock symbol: NOVN. Products include transdermal drug delivery systems.